See every side of every news story
Published loading...Updated

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Summary by Ground News
Cancer immunotherapeutics work by unleashing the power of a patient's immune system to fight cancer. The market, which was valued at US$ 96.40 billion in 2023, is estimated to achieve a remarkable CAGR of 10.02% between the years 2023 and 2030. projections placing its value at approximately US$ 188.11 billion by the end of the decade.

5 Articles

All
Left
Center
Right
1
Lean Right

They are called 'dagger' cells, after their English acronym -sTab-, a striking name that describes their way of acting. Luis Álvarez Vallina, 'father' explains it...

·Madrid, Spain
Read Full Article

American researchers are on the trail of a new technique that could make it possible to increase efficiency by a hundred times...

·Saint-Georges, Canada
Read Full Article

American researchers are on the trail of a new technique that could make it possible to multiply by one hundred the effectiveness of certain immune cells against cancer cells.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Acadie Nouvelle broke the news in on Wednesday, February 14, 2024.
Sources are mostly out of (0)